|
2024-07-08 |
2024-07-05 |
S
Sale
|
Perry Andrew
Chief Commercial Officer
Officer
|
1,337
-1.2%
2.51
USD 3,353
|
1,337
-1.2%
|
2.51
|
USD 3,353
|
|
|
2024-07-08 |
2024-07-05 |
S
Sale
|
Malik Rajesh
Chief Medical Officer
Officer
|
2,475
-1.5%
2.51
USD 6,207
|
2,475
-1.5%
|
2.51
|
USD 6,207
|
|
|
2024-07-08 |
2024-07-05 |
S
Sale
|
MURDOCK TERRY L
Chief Operating Officer
Officer
|
2,475
-1.9%
2.51
USD 6,207
|
2,475
-1.9%
|
2.51
|
USD 6,207
|
|
|
2024-07-08 |
2024-07-05 |
S
Sale
|
Bailey John E. (Jack) Jr.
President and CEO
Executive Director
|
7,662
-1.4%
2.51
USD 19,214
|
7,662
-1.4%
|
2.51
|
USD 19,214
|
|
|
2024-07-08 |
2024-07-05 |
S
Sale
|
Umstead John W. V
Chief Financial Officer
Officer
|
527
-0.3%
2.51
USD 1,322
|
527
-0.3%
|
2.51
|
USD 1,322
|
|
|
2024-07-08 |
2024-07-05 |
S
Sale
|
Avagliano Mark
Chief Business Officer
Officer
|
2,638
-1.1%
2.51
USD 6,615
|
2,638
-1.1%
|
2.51
|
USD 6,615
|
|
|
2024-05-24 |
2024-05-23 |
S
Sale
|
Thomas Monica R.
Chief Legal & People Officer
Officer
|
5,826
-5.0%
4.27
USD 24,864
|
5,826
-5.0%
|
4.27
|
USD 24,864
|
|
|
2024-05-15 |
2024-05-13 |
S
Sale
|
MURDOCK TERRY L
Chief Operating Officer
Officer
|
8,151
-7.9%
4.79
USD 39,034
|
8,151
-7.9%
|
4.79
|
USD 39,034
|
|
|
2024-05-15 |
2024-05-13 |
S
Sale
|
Malik Rajesh
Chief Medical Officer
Officer
|
8,151
-4.8%
4.79
USD 39,034
|
8,151
-4.8%
|
4.79
|
USD 39,034
|
|
|
2024-05-15 |
2024-05-13 |
S
Sale
|
Malik Rajesh
Chief Medical Officer
Officer
|
8,151
-4.8%
4.79
USD 39,034
|
8,151
-4.8%
|
4.79
|
USD 39,034
|
|
|
2024-05-15 |
2024-05-13 |
S
Sale
|
Avagliano Mark
Chief Business Officer
Officer
|
8,151
-3.7%
4.79
USD 39,034
|
8,151
-3.7%
|
4.79
|
USD 39,034
|
|
|
2024-05-15 |
2024-05-13 |
S
Sale
|
Umstead John W. V
Chief Financial Officer
Officer
|
8,151
-5.1%
4.79
USD 39,034
|
8,151
-5.1%
|
4.79
|
USD 39,034
|
|
|
2024-05-15 |
2024-05-13 |
S
Sale
|
Perry Andrew
Chief Commercial Officer
Officer
|
8,151
-9.4%
4.79
USD 39,034
|
8,151
-9.4%
|
4.79
|
USD 39,034
|
|
|
2024-05-15 |
2024-05-13 |
S
Sale
|
Bailey John E. (Jack) Jr.
President and CEO
Executive Director
|
37,258
-7.6%
4.79
USD 178,421
|
37,258
-7.6%
|
4.79
|
USD 178,421
|
|
|
2024-03-20 |
2024-03-18 |
S
Sale
|
Umstead John W. V
Chief Financial Officer
Officer
|
6,547
-5.0%
3.02
USD 19,752
|
6,547
-5.0%
|
3.02
|
USD 19,752
|
|
|
2024-02-13 |
2024-02-12 |
PS
Planned sale
|
Malik Rajesh
Chief Medical Officer
Officer
|
28,600
-14.4%
4.62
USD 132,143
|
28,600
-14.4%
|
4.62
|
USD 132,143
|
|
|
2024-01-08 |
2024-01-04 |
S
Sale
|
Avagliano Mark
Chief Business Officer
Officer
|
721
-0.6%
2.94
USD 2,121
|
721
-0.6%
|
2.94
|
USD 2,121
|
|
|
2024-01-08 |
2024-01-04 |
S
Sale
|
MURDOCK TERRY L
Chief Operating Officer
Officer
|
721
-0.7%
2.94
USD 2,121
|
721
-0.7%
|
2.94
|
USD 2,121
|
|
|
2024-01-08 |
2024-01-04 |
S
Sale
|
Umstead John W. V
Chief Financial Officer
Officer
|
111
-0.1%
2.94
USD 327
|
111
-0.1%
|
2.94
|
USD 327
|
|
|
2024-01-08 |
2024-01-04 |
S
Sale
|
Malik Rajesh
Chief Medical Officer
Officer
|
721
-0.4%
2.94
USD 2,121
|
721
-0.4%
|
2.94
|
USD 2,121
|
|
|
2024-01-08 |
2024-01-03 |
S
Sale
|
Avagliano Mark
Chief Business Officer
Officer
|
2,602
-2.1%
3.12
USD 8,115
|
2,602
-2.1%
|
3.12
|
USD 8,115
|
|
|
2024-01-08 |
2024-01-03 |
S
Sale
|
Avagliano Mark
Chief Business Officer
Officer
|
758
-0.6%
3.12
USD 2,364
|
758
-0.6%
|
3.12
|
USD 2,364
|
|
|
2024-01-08 |
2024-01-03 |
S
Sale
|
MURDOCK TERRY L
Chief Operating Officer
Officer
|
2,261
-2.1%
3.12
USD 7,052
|
2,261
-2.1%
|
3.12
|
USD 7,052
|
|
|
2024-01-08 |
2024-01-03 |
S
Sale
|
MURDOCK TERRY L
Chief Operating Officer
Officer
|
758
-0.7%
3.12
USD 2,364
|
758
-0.7%
|
3.12
|
USD 2,364
|
|
|
2024-01-08 |
2024-01-03 |
S
Sale
|
Bailey John E. (Jack) Jr.
President and CEO
Executive Director
|
9,094
-1.8%
3.12
USD 28,363
|
9,094
-1.8%
|
3.12
|
USD 28,363
|
|
|
2024-01-08 |
2024-01-03 |
S
Sale
|
Bailey John E. (Jack) Jr.
President and CEO
Executive Director
|
2,592
-0.5%
3.12
USD 8,084
|
2,592
-0.5%
|
3.12
|
USD 8,084
|
|
|
2024-01-08 |
2024-01-03 |
S
Sale
|
Umstead John W. V
Chief Financial Officer
Officer
|
379
-0.3%
3.12
USD 1,182
|
379
-0.3%
|
3.12
|
USD 1,182
|
|
|
2024-01-08 |
2024-01-03 |
S
Sale
|
Umstead John W. V
Chief Financial Officer
Officer
|
253
-0.2%
3.12
USD 789
|
253
-0.2%
|
3.12
|
USD 789
|
|
|
2024-01-08 |
2024-01-03 |
S
Sale
|
Malik Rajesh
Chief Medical Officer
Officer
|
2,261
-1.3%
3.12
USD 7,052
|
2,261
-1.3%
|
3.12
|
USD 7,052
|
|
|
2024-01-08 |
2024-01-03 |
S
Sale
|
Malik Rajesh
Chief Medical Officer
Officer
|
758
-0.4%
3.12
USD 2,364
|
758
-0.4%
|
3.12
|
USD 2,364
|
|
|
2024-01-08 |
2024-01-03 |
S
Sale
|
Perry Andrew
Chief Commercial Officer
Officer
|
2,034
-2.3%
3.12
USD 6,344
|
2,034
-2.3%
|
3.12
|
USD 6,344
|
|
|
2024-01-08 |
2024-01-03 |
S
Sale
|
Perry Andrew
Chief Commercial Officer
Officer
|
379
-0.4%
3.12
USD 1,182
|
379
-0.4%
|
3.12
|
USD 1,182
|
|
|
2024-01-02 |
2024-01-02 |
S
Sale
|
Bailey John E. (Jack) Jr.
President and CEO
Executive Director
|
32,983
-7.6%
3.27
USD 108,006
|
32,983
-7.6%
|
3.27
|
USD 108,006
|
|
|
2023-12-13 |
2023-12-11 |
PS
Planned sale
|
Malik Rajesh
Chief Medical Officer
Officer
|
12,400
-8.3%
4.02
USD 49,863
|
12,400
-8.3%
|
4.02
|
USD 49,863
|
|
|
2023-12-13 |
2023-12-11 |
PS
Planned sale
|
Malik Rajesh
Chief Medical Officer
Officer
|
21,439
-13.6%
3.06
USD 65,659
|
21,439
-13.6%
|
3.06
|
USD 65,659
|
|
|
2023-08-10 |
2023-08-08 |
PS
Planned sale
|
Velleca Mark A.
Non-Executive Director
|
2,714
-2.3%
2.02
USD 5,482
|
2,714
-2.3%
|
2.02
|
USD 5,482
|
|
|
2023-08-10 |
2023-08-08 |
PS
Planned sale
|
Velleca Mark A.
Non-Executive Director
|
57,286
-33.1%
2.00
USD 114,492
|
57,286
-33.1%
|
2.00
|
USD 114,492
|
|
|
2023-07-07 |
2023-07-05 |
PS
Planned sale
|
Malik Rajesh
Chief Medical Officer
Officer
|
1,361
-1.0%
2.45
USD 3,339
|
1,361
-1.0%
|
2.45
|
USD 3,339
|
|
|
2023-07-07 |
2023-07-05 |
PS
Planned sale
|
MURDOCK TERRY L
Chief Operating Officer
Officer
|
1,361
-1.9%
2.45
USD 3,339
|
1,361
-1.9%
|
2.45
|
USD 3,339
|
|
|
2023-07-07 |
2023-07-05 |
PS
Planned sale
|
Bailey John E. (Jack) Jr.
President and CEO
Executive Director
|
2,719
-0.6%
2.45
USD 6,672
|
2,719
-0.6%
|
2.45
|
USD 6,672
|
|
|
2023-07-07 |
2023-07-05 |
PS
Planned sale
|
Perry Andrew
Chief Commercial Officer
Officer
|
355
-0.6%
2.45
USD 871
|
355
-0.6%
|
2.45
|
USD 871
|
|
|
2023-01-05 |
2023-01-05 |
S
Sale
|
Moses Jennifer K.
CFO
Officer
|
729
-1.2%
5.41
USD 3,942
|
729
-1.2%
|
5.41
|
USD 3,942
|
|
|
2023-01-05 |
2023-01-05 |
S
Sale
|
MURDOCK TERRY L
Chief Operating Officer
Officer
|
729
-2.0%
5.41
USD 3,942
|
729
-2.0%
|
5.41
|
USD 3,942
|
|
|
2023-01-05 |
2023-01-05 |
S
Sale
|
Hanson James S.
General Counsel
Officer
|
729
-1.7%
5.41
USD 3,942
|
729
-1.7%
|
5.41
|
USD 3,942
|
|
|
2023-01-05 |
2023-01-05 |
S
Sale
|
Malik Rajesh
Chief Medical Officer
Officer
|
729
-0.7%
5.41
USD 3,942
|
729
-0.7%
|
5.41
|
USD 3,942
|
|
|
2023-01-05 |
2023-01-04 |
S
Sale
|
Bailey John E. (Jack) Jr.
President and CEO
Executive Director
|
5,607
-2.0%
5.58
USD 31,262
|
5,607
-2.0%
|
5.58
|
USD 31,262
|
|
|
2023-01-05 |
2023-01-04 |
S
Sale
|
Perry Andrew
Chief Commercial Officer
Officer
|
820
-3.7%
5.58
USD 4,572
|
820
-3.7%
|
5.58
|
USD 4,572
|
|
|
2023-01-05 |
2023-01-04 |
S
Sale
|
Moses Jennifer K.
CFO
Officer
|
1,639
-2.7%
5.58
USD 9,138
|
1,639
-2.7%
|
5.58
|
USD 9,138
|
|
|
2023-01-05 |
2023-01-04 |
S
Sale
|
MURDOCK TERRY L
Chief Operating Officer
Officer
|
1,639
-4.2%
5.58
USD 9,138
|
1,639
-4.2%
|
5.58
|
USD 9,138
|
|
|
2023-01-05 |
2023-01-04 |
S
Sale
|
Hanson James S.
General Counsel
Officer
|
1,639
-3.8%
5.58
USD 9,138
|
1,639
-3.8%
|
5.58
|
USD 9,138
|
|
|
2023-01-05 |
2023-01-04 |
S
Sale
|
Malik Rajesh
Chief Medical Officer
Officer
|
1,639
-1.6%
5.58
USD 9,138
|
1,639
-1.6%
|
5.58
|
USD 9,138
|
|
|
2023-01-05 |
2023-01-03 |
S
Sale
|
Bailey John E. (Jack) Jr.
President and CEO
Executive Director
|
32,019
-10.2%
5.85
USD 187,452
|
32,019
-10.2%
|
5.85
|
USD 187,452
|
|
|
2022-10-20 |
2022-10-18 |
PS
Planned sale
|
Velleca Mark A.
Non-Executive Director
|
15,000
-11.5%
11.70
USD 175,490
|
15,000
-11.5%
|
11.70
|
USD 175,490
|
|
|
2022-09-22 |
2022-09-20 |
PS
Planned sale
|
Velleca Mark A.
Non-Executive Director
|
20,000
-14.7%
13.50
USD 270,044
|
20,000
-14.7%
|
13.50
|
USD 270,044
|
|
|
2022-09-16 |
2022-09-13 |
PS
Planned sale
|
Malik Rajesh
Chief Medical Officer
Officer
|
18,000
-19.7%
15.71
USD 282,746
|
18,000
-19.7%
|
15.71
|
USD 282,746
|
|
|
2022-08-18 |
2022-08-16 |
PS
Planned sale
|
Velleca Mark A.
Non-Executive Director
|
80,000
-40.8%
12.64
USD 1,010,904
|
80,000
-40.8%
|
12.64
|
USD 1,010,904
|
|
|
2022-07-06 |
2022-07-05 |
S
Sale
|
Malik Rajesh
Chief Medical Officer
Officer
|
648
-0.9%
5.17
USD 3,351
|
648
-0.9%
|
5.17
|
USD 3,351
|
|
|
2022-07-06 |
2022-07-05 |
S
Sale
|
MURDOCK TERRY L
Chief Operating Officer
Officer
|
648
-3.0%
5.17
USD 3,351
|
648
-3.0%
|
5.17
|
USD 3,351
|
|
|
2022-01-05 |
2022-01-05 |
S
Sale
|
MURDOCK TERRY L
Chief Operating Officer
Officer
|
1,445
-6.3%
10.61
USD 15,334
|
1,445
-6.3%
|
10.61
|
USD 15,334
|
|
|
2022-01-05 |
2022-01-05 |
S
Sale
|
Hanson James S.
General Counsel
Officer
|
1,445
-5.4%
10.61
USD 15,334
|
1,445
-5.4%
|
10.61
|
USD 15,334
|
|
|
2022-01-05 |
2022-01-05 |
S
Sale
|
Avagliano Mark
Chief Business Officer
Officer
|
1,445
-6.3%
10.61
USD 15,334
|
1,445
-6.3%
|
10.61
|
USD 15,334
|
|
|
2022-01-05 |
2022-01-05 |
S
Sale
|
Malik Rajesh
Chief Medical Officer
Officer
|
1,445
-2.2%
10.61
USD 15,334
|
1,445
-2.2%
|
10.61
|
USD 15,334
|
|
|
2022-01-05 |
2022-01-05 |
S
Sale
|
Moses Jennifer K.
CFO
Officer
|
1,445
-3.9%
10.61
USD 15,334
|
1,445
-3.9%
|
10.61
|
USD 15,334
|
|
|
2022-01-05 |
2022-01-03 |
S
Sale
|
Bailey John E. (Jack) Jr.
President and CEO
Executive Director
|
34,125
-12.8%
10.41
USD 355,262
|
34,125
-12.8%
|
10.41
|
USD 355,262
|
|
|
2021-06-17 |
2021-06-17 |
PS
Planned sale
|
Velleca Mark A.
Non-Executive Director
|
10,000
-14.1%
21.77
USD 217,728
|
10,000
-14.1%
|
21.77
|
USD 217,728
|
|
|
2021-06-17 |
2021-06-16 |
PS
Planned sale
|
Velleca Mark A.
Non-Executive Director
|
10,000
-14.1%
21.74
USD 217,384
|
10,000
-14.1%
|
21.74
|
USD 217,384
|
|
|
2021-06-17 |
2021-06-15 |
PS
Planned sale
|
Velleca Mark A.
Non-Executive Director
|
10,000
-14.1%
22.39
USD 223,909
|
10,000
-14.1%
|
22.39
|
USD 223,909
|
|
|
2021-05-13 |
2021-05-13 |
PS
Planned sale
|
Velleca Mark A.
Non-Executive Director
|
10,000
-19.6%
20.54
USD 205,413
|
10,000
-19.6%
|
20.54
|
USD 205,413
|
|
|
2021-05-13 |
2021-05-12 |
PS
Planned sale
|
Velleca Mark A.
Non-Executive Director
|
10,000
-19.6%
20.07
USD 200,691
|
10,000
-19.6%
|
20.07
|
USD 200,691
|
|
|
2021-05-13 |
2021-05-11 |
PS
Planned sale
|
Velleca Mark A.
Non-Executive Director
|
10,000
-19.6%
19.10
USD 190,997
|
10,000
-19.6%
|
19.10
|
USD 190,997
|
|
|
2021-04-23 |
2021-04-22 |
PS
Planned sale
|
Malik Rajesh
Chief Medical Officer
Officer
|
15,000
-25.7%
22.07
USD 331,100
|
15,000
-25.7%
|
22.07
|
USD 331,100
|
|
|
2021-04-15 |
2021-04-15 |
PS
Planned sale
|
Velleca Mark A.
Non-Executive Director
|
10,000
-19.6%
24.96
USD 249,631
|
10,000
-19.6%
|
24.96
|
USD 249,631
|
|
|
2021-04-15 |
2021-04-14 |
PS
Planned sale
|
Velleca Mark A.
Non-Executive Director
|
10,000
-19.6%
24.53
USD 245,272
|
10,000
-19.6%
|
24.53
|
USD 245,272
|
|
|
2021-04-15 |
2021-04-13 |
PS
Planned sale
|
Velleca Mark A.
Non-Executive Director
|
10,000
-19.6%
23.89
USD 238,865
|
10,000
-19.6%
|
23.89
|
USD 238,865
|
|
|
2021-03-24 |
2021-03-23 |
PS
Planned sale
|
Malik Rajesh
Chief Medical Officer
Officer
|
15,000
-25.7%
21.94
USD 329,060
|
15,000
-25.7%
|
21.94
|
USD 329,060
|
|
